Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: New-onset diabetes after kidney transplantation (NODAT) is associated with both renal allograft failure and increased mortality. The objective of this meta-analysis was to evaluate the risk of NODAT in patients with hypomagnesemia. METHODS: A literature search was performed using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from inception through May, 2015. Studies that reported relative risks, odd ratios or hazard ratios comparing the risk of NODAT in patients with hypomagnesemia were included. Pooled risk ratios (RR) and 95% confidence interval (CI) were calculated using a random-effect, generic inverse variance method. RESULTS: Five cohort studies with 1699 patients were included in the analysis to assess the risk of NODAT in patients with hypomagnesemia. The pooled RR of NODAT in patients with hypomagnesemia was 1.25 (95% CI, 1.08-1.45). When meta-analysis was limited only to studies with the post-transplant hypomagnesemia, the pooled RR of NODAT was 1.22 (95% CI, 1.09-1.38). CONCLUSION: Our meta-analysis demonstrates a significant association between hypomagnesemia and NODAT in kidney transplant recipients. This finding suggests the need for a large randomized controlled trial-with very careful attention to assess the effects of normalizing Mg levels and the risk of NODAT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and also prevents progression from prediabetes to T2D.1571–1574”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1572]
In the citing paper
“testosterone replacement improves glycemia, dyslipidemia, hepatic steatosis, body composition, and CVD risk”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1572]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird (29).”
MethodAssessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · cited 1×
“The quality of each study was independently evaluated by each investigator using Jadad quality assessment scale (27) for RCTs and NewcastleOttawa quality assessment scale (28) for observational studies.”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“The quality of each study was independently evaluated by each investigator using Jadad quality assessment scale (27) for RCTs and NewcastleOttawa quality assessment scale (28) for observational studies.”
MethodPublication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · cited 1×
“The presence of publication bias was assessed by funnel plots of the logarithm of odds ratios versus their standard errors (31).”
MethodDiabetes Mellitus after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D., & Matas, A. J. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00010.x · Cited by 1,285
Fiber and Magnesium Intake and Incidence of Type 2 Diabetes: A Prospective Study and Meta-analysis
Schulze, M. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.956 · Cited by 537 · cited 1×
“In addition, hypomagnesemia is now considered as a potential risk factor for developing diabetes mellitus (19) and adequate Mg balance has been demonstrated to reduce the risk of diabetes mellitus type 2 in non-transplant patients (20,21).”
BackgroundHeisel, O., Heisel, R., Balshaw, R., & Keown, P. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00372.x · Cited by 506
Magnesium Intake and Risk of Type 2 Diabetes in Men and Women
Lopez-Ridaura, R., Willett, W. C., Rimm, E. B., Liu, S., Stampfer, M. J., Manson, J. E., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.134 · Cited by 455 · cited 1×
“Lastly, although studies in healthy subjects and diabetic patients have shown that increasing Mg intakes can reduce the risk of insulin resistance (39-41), the evidence of normalizing Mg levels and the risk of NODAT is limited.”
BackgroundHypomagnesemia in Patients with Type 2 Diabetes
Pham, P.-C. T., Pham, P.-M. T., Pham, S. V., Miller, J. M., & Pham, P.-T. T. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02960906 · Cited by 436 · cited 1×
“In addition, hypomagnesemia is now considered as a potential risk factor for developing diabetes mellitus (19) and adequate Mg balance has been demonstrated to reduce the risk of diabetes mellitus type 2 in non-transplant patients (20,21).”
BackgroundPatient survival after renal transplantation: IV. Impact of post-transplant diabetes
Cosio, F. G., Pesavento, T. E., Kim, S., Osei, K., Henry, M., & Ferguson, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00582.x · Cited by 422 · cited 1×
“New-onset diabetes after transplantation (NODAT) is a serious complication in postkidney transplant recipients and is independently associated with allograft failure (1,2) and mortality (1,3,4).”
BackgroundWoodward, R. S., Schnitzler, M. A., Baty, J., Lowell, J. A., Lopez-Rocafort, L., Haider, S., Woodworth, T. G., & Brennane, D. C. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00082.x · Cited by 402 · cited 1×
“A number of studies have previously identified risk factors for NODAT such as obesity (5), metabolic syndrome (6), hepatitis C virus(1,7), cytomegalovirus infection (8), corticosteroids use (5) and calcineurin inhibitors (CNIs) especially tacrolimus (1,9).”
BackgroundCosio, F. G., Pesavento, T. E., Osei, K., Henry, M. L., & Ferguson, R. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002732.x · Cited by 381
Magnesium and glucose homeostasis
Paolisso, G., Scheen, A., D'Onofrio, F., & Lef�bvre, P. (1990) · Diabetologia · doi:10.1007/bf00404136 · Cited by 270 · cited 1×
“Magnesium (Mg) provides many functions in biochemical reactions (13–16) and plays an important role in glucose metabolism (17,18).”
BackgroundMiles, A. M. V., Sumrani, N., Horowitz, R., Homel, P., Maursky, V., Markell, M. S., Distant, D. A., Hong, J. H., Sommer, B. G., & Friendman, E. A. (1998) · Transplantation · doi:10.1097/00007890-199802150-00014 · Cited by 268 · cited 1×
“New-onset diabetes after transplantation (NODAT) is a serious complication in postkidney transplant recipients and is independently associated with allograft failure (1,2) and mortality (1,3,4).”
BackgroundGuerrero-Romero, F., Tamez-Perez, H., González-González, G., Salinas-Martínez, A., Montes-Villarreal, J., Treviño-Ortiz, J., & Rodríguez-Morán, M. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70116-7 · Cited by 236 · cited 1×
“Lastly, although studies in healthy subjects and diabetic patients have shown that increasing Mg intakes can reduce the risk of insulin resistance (39-41), the evidence of normalizing Mg levels and the risk of NODAT is limited.”
BackgroundHjelmes�th, J., Sagedal, S., Hartmann, A., Rollag, H., Egeland, T., Hagen, M., Nordal, K. P., & Jenssen, T. (2004) · Diabetologia · doi:10.1007/s00125-004-1499-z · Cited by 228 · cited 1×
“A number of studies have previously identified risk factors for NODAT such as obesity (5), metabolic syndrome (6), hepatitis C virus(1,7), cytomegalovirus infection (8), corticosteroids use (5) and calcineurin inhibitors (CNIs) especially tacrolimus (1,9).”
BackgroundCheungpasitporn, W., Thongprayoon, C., Kittanamongkolchai, W., Srivali, N., Edmonds, P. J., Ungprasert, P., O'Corragain, O. A., Korpaisarn, S., & Erickson, S. B. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1057800 · Cited by 215 · cited 1×
“In general populations, hypomagnesemia is considered a potential risk factors for type 2 diabetes mellitus (14).”
BackgroundSelf-citationFabrizi, F., Martin, P., Dixit, V., Bunnapradist, S., Kanwal, F., & Dulai, G. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01040.x · Cited by 208 · cited 1×
“A number of studies have previously identified risk factors for NODAT such as obesity (5), metabolic syndrome (6), hepatitis C virus(1,7), cytomegalovirus infection (8), corticosteroids use (5) and calcineurin inhibitors (CNIs) especially tacrolimus (1,9).”
BackgroundNew-Onset Diabetes after Kidney Transplantation: Risk Factors
Rodrigo, E., Fernández-Fresnedo, G., Valero, R., Ruiz, J. C., Piñera, C., Palomar, R., González-Cotorruelo, J., Gómez-Alamillo, C., & Arias, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080929 · Cited by 172 · cited 1×
“A number of studies have previously identified risk factors for NODAT such as obesity (5), metabolic syndrome (6), hepatitis C virus(1,7), cytomegalovirus infection (8), corticosteroids use (5) and calcineurin inhibitors (CNIs) especially tacrolimus (1,9).”
BackgroundVan Laecke, S., Van Biesen, W., Verbeke, F., De Bacquer, D., Peeters, P., & Vanholder, R. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02752.x · Cited by 145 · cited 5×
“Of 5 studies, 4 studies evaluated Mg levels at 1 month post-transplantation (22,23,25,26).”
BackgroundInfluentialNew-Onset Diabetes After Renal Transplantation
Ghisdal, L., Van Laecke, S., Abramowicz, M. J., Vanholder, R., & Abramowicz, D. (2012) · Diabetes Care · doi:10.2337/dc11-1230 · Cited by 128
Dysmagnesemia in Hospitalized Patients: Prevalence and Prognostic Importance
Cheungpasitporn, W., Thongprayoon, C., & Qian, Q. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.04.023 · Cited by 122 · cited 1×
“Magnesium (Mg) provides many functions in biochemical reactions (13–16) and plays an important role in glucose metabolism (17,18).”
BackgroundSelf-citationBelin, R. J., & He, K. (2007) · PubMed · Cited by 108
Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats
Tongyai, S., Rayssiguier, Y., Motta, C., Gueux, E., Maurois, P., & Heaton, F. W. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.257.2.c270 · Cited by 75 · cited 1×
“Several studies have previously shown hypomagnesemia may reduce insulin sensitivity by altering cellular glucose transport and insulin–insulin receptor interactions (33,34).”
BackgroundIsrani, A. K., Snyder, J. J., Skeans, M. A., Kasiske, B. L., & for the PORT Investigators (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01488.x · Cited by 69 · cited 1×
“A number of studies have previously identified risk factors for NODAT such as obesity (5), metabolic syndrome (6), hepatitis C virus(1,7), cytomegalovirus infection (8), corticosteroids use (5) and calcineurin inhibitors (CNIs) especially tacrolimus (1,9).”
BackgroundMandon‐Pepin, B., Siga, E., Chabardès, D., Firsov, D., Roinel, N., & de Rouffignac, C. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.3.f361 · Cited by 67 · cited 1×
“Hypomagnesemia is a common electrolyte abnormality in patients with diabetes mellitus due to osmotic diuresis from glucosuria and impaired Mg absorption in the thick ascending limb of Henle related to insulin resistance both contribute to hypomagnesemia (22,32).”
BackgroundHypomagnesemia and the risk of new-onset diabetes after liver transplantation
Laecke, S. V., Desideri, F., Geerts, A. M., Vlierberghe, H. V., Berrevoet, F. C., Rogiers, X., TROISI, R. I., de Hemptinne, B., Vanholder, R. C., & Colle, I. O. (2010) · Liver Transplantation · doi:10.1002/lt.22146 · Cited by 59 · cited 1×
“(38) recently reported an increased risk of NODAT in liver transplant patient population, the risk of NODAT in patients with other types of solid organ transplantation with hypomagnesemia is still unclear.”
BackgroundHypomagnesaemia linked to depression: A systematic review and meta-analysis
Cheungpasitporn, W., Thongprayoon, C., Mao, M. A., Srivali, N., Ungprasert, P., Varothai, N., Sanguankeo, A., Kittanamongkolchai, W., & Erickson, S. B. (2015) · Internal Medicine Journal · doi:10.1111/imj.12682 · Cited by 57
Self-citationMagnesium Intake and the Metabolic Syndrome: Epidemiologic Evidence to Date
He, K., Song, Y., Belin, R. J., & Chen, Y. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05702.x · Cited by 53 · cited 1×
“Lastly, although studies in healthy subjects and diabetic patients have shown that increasing Mg intakes can reduce the risk of insulin resistance (39-41), the evidence of normalizing Mg levels and the risk of NODAT is limited.”
BackgroundNew-onset diabetes after transplantation: Risk factors and clinical impact
Räkel, A., & Karelis, A. D. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.003 · Cited by 52
Laecke, S. V., Nagler, E. V., Taes, Y., Biesen, W. V., Peeters, P. C., & Vanholder, R. C. (2014) · Transplant International · doi:10.1111/tri.12287 · Cited by 51 · cited 1×
“(42) conducted randomized controlled trial evaluating the effect of magnesium supplements on early post transplantation glucose metabolism and found that high doses of magnesium oxide had a beneficial but minor effect on glycemic control.”
BackgroundAdmission hypomagnesemia and hypermagnesemia increase the risk of acute kidney injury
Cheungpasitporn, W., Thongprayoon, C., & Erickson, S. B. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1057471 · Cited by 50
Self-citationAugusto, J., Subra, J., Duveau, A., Rakotonjanahary, J., Dussaussoy, C., Picquet, J., Croué, A., Villemain, F., Onno, C., & Sayegh, J. (2014) · Transplantation · doi:10.1097/01.tp.0000440950.22133.a1 · Cited by 41 · cited 4×
“Three studies performed adjusted analysis for known risk factors for NODAT (22,24,26).”
BackgroundMethodInfluentialDiabetes mellitus--a more-common-than-believed complication of renal transplantation.
GUNNARSSON, R., Arner, P., Lundgren, G., Magnússon, G., Östman, J., & Groth, C. G. (1979) · PubMed · Cited by 38
The Effect of Magnesium Deficiency on Glucose Stimulated Insulin Secretion in Rats
Gueux, E., & Rayssiguier, Y. (1983) · Hormone and Metabolic Research · doi:10.1055/s-2007-1018801 · Cited by 35 · cited 1×
“Moreover, hypomagnesemia can reduce insulin secretion in rats (35).”
BackgroundAdmission serum magnesium levels and the risk of acute respiratory failure
Thongprayoon, C., Cheungpasitporn, W., Srivali, N., & Erickson, S. B. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12696 · Cited by 34
Self-citationGarg, N., Weinberg, J., Ghai, S., Bradauskaite, G., Nuhn, M. G., Gautam, A., Kumar, N., Francis, J. M., & Chen, J. L. T. (2014) · Journal of Nephrology · doi:10.1007/s40620-014-0072-1 · Cited by 29 · cited 4×
“Conversely, several studies have found no significant association(25,26).”
BackgroundInfluentialGonzález‐Posada, J. M., Hernández, D., Genís, B. B., Tamajón, L. P., Pérez, J. G., Maceira, B., Sánchez, M. R., Serón, D., & for the Spanish Chronic Allograft Nephropathy Study Group (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00532.x · Cited by 26 · cited 1×
“New-onset diabetes after transplantation (NODAT) is a serious complication in postkidney transplant recipients and is independently associated with allograft failure (1,2) and mortality (1,3,4).”
BackgroundSantos, L., Rodrigo, E., Piñera, C., Robledo, C., Palomar, R., Gómez-Alamillo, C., González-Cotorruelo, J., & Arias, M. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.07.057 · Cited by 17 · cited 3×
“Conversely, several studies have found no significant association(25,26).”
BackgroundThe role of magnesium deficiency in insulin resistance
Dz??rik, R., Stef??kov??, K., Spustov??, V., & Fetkovsk??, N. (1991) · Journal of Hypertension · doi:10.1097/00004872-199112000-00140 · Cited by 14 · cited 1×
“Several studies have previously shown hypomagnesemia may reduce insulin sensitivity by altering cellular glucose transport and insulin–insulin receptor interactions (33,34).”
BackgroundIs Hypomagnesemia a Novel Risk Factor for New-Onset Diabetes Mellitus After Kidney Transplantation?
Huang, J., Famure, O., Li, Y., & Kim, S. (2014) · Transplantation · doi:10.1097/00007890-201407151-00293 · Cited by 2
Effects of linoleic acid supplementation on blood pressure and kinetics of red cell sodium transport
Semplicini, A., Casiglia, E., Marzola, M., Ceolotto, G., Businaro, R., Olivieri, O., Guarini, P., Corrocher, R., Martines, C., & Palù, C. D. (1991) · Journal of Hypertension · doi:10.1097/00004872-199112006-00139 · Cited by 1
Research works printed but not linked: 5
- 10.1111/j.1523-1755.2002.kid582.x · doi:10.1111/j.1523-1755.2002.kid582.x · Paper page
- Gunnarsson R, 1979, Transplant Proc, 11, 1280
- Belin RJ, 2007, Magnes Res, 20, 107
- Mandon B, 1993, Am J Physiol, 265, F361
- Guerrero-Romero F, 2004, A double-blind placebo-controlled randomized trial. Diabetes Metab, 30, 253
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
Farouk, S. S., & Rein, J. L. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.08.006 · Cited by 234
Veronese, N., Demurtas, J., Pesolillo, G., Celotto, S., Barnini, T., Calusi, G., Caruso, M. G., Notarnicola, M., Reddavide, R., Stubbs, B., et al. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01905-w · Cited by 125
Recent Advances and Clinical Outcomes of Kidney Transplantation
Thongprayoon, C., Hansrivijit, P., Leeaphorn, N., Acharya, P. C., Torres‐Ortiz, A., Kaewput, W., Kovvuru, K. R., Kanduri, S. R., Bathini, T. J., & Cheungpasitporn, W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041193 · Cited by 111
“Preexisting diabetes and post-transplantation diabetes confer reduced patient and graft survival in kidney transplant recipients [71,73,125].”
BackgroundSelf-citationNew-Onset Diabetes after Kidney Transplantation
Ponticelli, C. E., Favi, E., & Ferraresso, M. (2021) · Medicina · doi:10.3390/medicina57030250 · Cited by 66
“Therefore, interventions targeting serum magnesium to reduce the risk of NODAT may be convenient [56].”
Background
Metadata
- Authors
- Cheungpasitporn, W., Thongprayoon, C., Harindhanavudhi, T., Edmonds, P. J., & Erickson, S. B.
- Affiliations
- Mayo Clinic (US)
- University of Minnesota (US)
- SUNY Upstate Medical University (US)
- Corresponding author
- Cheungpasitporn, Wisit
- Venue
- Endocrine Research
- Publisher
- Informa UK Limited
- Published
- 2016-03-02
- Volume
- 41
- Issue
- 2
- Pages
- 142-147
- ISSN
- 0743-5800 (ISSN-L)
- 1532-4206
- OpenAlex
- W2289246896
- Cited by
- 40
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 4 · 2016: 1
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Magnesium in Health and Disease
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Physical Sciences › Materials Science › Biomaterials › Magnesium Alloys: Properties and Applications
- Keywords
- hypomagnesemia, kidney transplantation, magnesium supplementation, renal allograft failure, transplant recipient mortality
- MeSH terms
- Diabetes Mellitus, Humans, Magnesium Deficiency, Kidney Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.